Literature DB >> 15340145

Cycling antibiotics may not be good for your health.

Bruce R Levin1, Marc J M Bonten.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15340145      PMCID： PMC516530          DOI： 10.1073/pnas.0404970101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  17 in total

1.  Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data.

Authors:  Hajo Grundmann; Satoshi Hori; Bob Winter; Adriana Tami; Daren J Austin
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

Review 2.  Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control.

Authors:  M J Bonten; D J Austin; M Lipsitch
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

3.  Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals.

Authors:  Carl T Bergstrom; Monique Lo; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-12       Impact factor: 11.205

4.  Antibiotic resistance--squeezing the balloon?

Authors:  J P Burke
Journal:  JAMA       Date:  1998-10-14       Impact factor: 56.272

5.  Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience.

Authors:  C M Vandenbroucke-Grauls
Journal:  Infect Control Hosp Epidemiol       Date:  1996-08       Impact factor: 3.254

6.  Monitoring hospital-acquired infections to promote patient safety--United States, 1990-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-03-03       Impact factor: 17.586

7.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

Authors:  Sara E Cosgrove; George Sakoulas; Eli N Perencevich; Mitchell J Schwaber; Adolf W Karchmer; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2002-12-13       Impact factor: 9.079

8.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.

Authors:  J J Rahal; C Urban; D Horn; K Freeman; S Segal-Maurer; J Maurer; N Mariano; S Marks; J M Burns; D Dominick; M Lim
Journal:  JAMA       Date:  1998-10-14       Impact factor: 56.272

9.  Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes.

Authors:  B S Cooper; G F Medley; S P Stone; C C Kibbler; B D Cookson; J A Roberts; G Duckworth; R Lai; S Ebrahim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

10.  Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Authors:  Francois Vandenesch; Timothy Naimi; Mark C Enright; Gerard Lina; Graeme R Nimmo; Helen Heffernan; Nadia Liassine; Michèle Bes; Timothy Greenland; Marie-Elisabeth Reverdy; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883
View more
  12 in total

1.  Active use of the metapleural glands by ants in controlling fungal infection.

Authors:  Hermógenes Fernández-Marín; Jess K Zimmerman; Stephen A Rehner; William T Wcislo
Journal:  Proc Biol Sci       Date:  2006-07-07       Impact factor: 5.349

2.  A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development.

Authors:  Lucas Böttcher; Hans Gersbach
Journal:  Bull Math Biol       Date:  2022-04-22       Impact factor: 3.871

3.  The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection.

Authors:  Andrew N Ginn; Agnieszka M Wiklendt; Heather F Gidding; Narelle George; James S O'Driscoll; Sally R Partridge; Brian I O'Toole; Rita A Perri; Joan Faoagali; John E Gallagher; Jeffrey Lipman; Jonathan R Iredell
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

4.  Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.

Authors:  Gabriel G Perron; R Fredrik Inglis; Pleuni S Pennings; Sarah Cobey
Journal:  Evol Appl       Date:  2015-03-23       Impact factor: 5.183

5.  Antibiotic Cycling and Antibiotic Mixing: Which One Best Mitigates Antibiotic Resistance?

Authors:  Robert Eric Beardmore; Rafael Peña-Miller; Fabio Gori; Jonathan Iredell
Journal:  Mol Biol Evol       Date:  2017-04-01       Impact factor: 16.240

6.  Cycling empirical antibiotic therapy in hospitals: meta-analysis and models.

Authors:  Pia Abel zur Wiesch; Roger Kouyos; Sören Abel; Wolfgang Viechtbauer; Sebastian Bonhoeffer
Journal:  PLoS Pathog       Date:  2014-06-26       Impact factor: 6.823

7.  Pharmacodynamic considerations of collateral sensitivity in design of antibiotic treatment regimen.

Authors:  Klas I Udekwu; Howard Weiss
Journal:  Drug Des Devel Ther       Date:  2018-07-23       Impact factor: 4.162

Review 8.  Unpacking factors influencing antimicrobial use in global aquaculture and their implication for management: a review from a systems perspective.

Authors:  Patrik J G Henriksson; Andreu Rico; Max Troell; Dane H Klinger; Alejandro H Buschmann; Sonja Saksida; Mohan V Chadag; Wenbo Zhang
Journal:  Sustain Sci       Date:  2017-11-18       Impact factor: 6.367

Review 9.  Microbial drug discovery: 80 years of progress.

Authors:  Arnold L Demain; Sergio Sanchez
Journal:  J Antibiot (Tokyo)       Date:  2009-01-09       Impact factor: 2.649

10.  Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea.

Authors:  Carolin Vegvari; Yonatan H Grad; Peter J White; Xavier Didelot; Lilith K Whittles; Nicole E Scangarella-Oman; Fanny S Mitrani-Gold; Etienne Dumont; Caroline R Perry; Kim Gilchrist; Mohammad Hossain; Tatum D Mortimer; Roy M Anderson; David Gardiner
Journal:  Euro Surveill       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.